HTRF Human Total JAK3 Detection Kit HTRF®

Associated products

The Total JAK3 kit is designed to monitor the expression level of cellular JAK3.

No-wash
High sensitivity
All inclusive kit
Low sample consumption

Download the protocols

The Total JAK3 kit is designed to monitor the expression level of cellular JAK3.

Size

Cat. number selected :

Quantity

In stock

Overview

The Human Total JAK3 detection assay monitors cellular JAK3 protein levels.

The Janus family kinases JAK1, JAK2, JAK3, and TYK2 are non-receptor protein tyrosine kinases that signal downstream cytokine receptors (mainly IL-R and IFN-R) and activate the STAT transcription factors. A specific JAK/JAK combination associates with a specific receptor and gives specificity to the downstream JAK/STAT signaling pathway. JAK3, in combination with JAK1, associates exclusively with the IL-2Rγ family receptors, and triggers the activation of the transcription factors STAT1, STAT3, STAT5, and STAT6 to regulate lymphocyte maturation, survival, activation, and differentiation.

JAK3 dysregulation has been reported in cancer and immune disorders. The main therapeutic strategies consist in developing potent and selective inhibitors/degraders of JAK3.

Benefits

SPECIFICITY
PRECISION

Total JAK3 assay principle

The Total JAK3 assay quantifies the expression level of JAK3 in a cell lysate. Unlike Western Blot, the assay is entirely plate-based and does not require gels, electrophoresis, or transfer. The Total JAK3 assay uses two labeled antibodies, one coupled to a donor fluorophore and the other to an acceptor. Both antibodies are highly specific for a distinct epitope on the protein. In the presence of JAK3 in a cell extract, the addition of these conjugates brings the donor fluorophore into close proximity with the acceptor and thereby generates a FRET signal. Its intensity is directly proportional to the concentration of the protein present in the sample, and provides a means of assessing the protein's expression under a no-wash assay format.

Total JAK3 two-plate assay protocol

The two-plate protocol involves culturing cells in a 96-well plate before lysis, then transferring lysates into a 384-well low volume detection plate before the addition of Total JAK3 HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.

2-plate protocol of the HTRF total JAK3 assay

Total JAK3 one-plate assay protocol

Detection of Total JAK3 with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required. This HTS designed protocol enables miniaturization while maintaining robust HTRF quality.

1-plate protocol of the HTRF total JAK3 assay

siRNA-mediated JAK3 downregulation

HEL cells were treated with 2.5 µM of Accell siRNA (Horizon) targeting specifically JAK3 or with a non-targeting siRNA (included as control) in a 96-well plate (200,000 cells/well) under 100 µL. After 48h incubation at 37°C, 50 µL of complete culture medium was added and the cells were incubated for an additional 24h-incubation at 37°C. After plate centrifugation, the cells were lysed with 50 µL of supplemented lysis buffer #4 (1X) and 16 µL of lysates were transferred into a low volume white microplate before the addition of 4 µL of premixed HTRF Total JAK3 detection antibodies. The HTRF signal was recorded after a 3h-incubation at RT.

Cell treatment with JAK3 siRNA led to a significant downregulation of JAK3 as highlighted by the 84% signal decrease compared to the cells transfected with the non-targeting siRNA.

Cell density experiments on several human cell lines

The suspension human cell lines HEL, U-937 and Jurkat were dispensed under 30 µL at different cell densities in a 96-well half-area plate, and lysed with 10 µL of supplemented lysis buffer #4 (4X). For HTRF detection of JAK3 protein levels, 16 µL of cell lysate were transferred into a low volume white microplate and 4 µL of premixed HTRF Total JAK3 detection antibodies were added. The HTRF signal was recorded after a 3h-incubation at RT.

Total JAK3 assay validation on HEL cells

Total JAK3 assay validation on U-937 cells

Total JAK3 assay validation on Jurkat cells

HTRF total JAK3 assay compared to Western Blot

U-937 cells were cultured in a T175 flask in complete culture medium. After 48h incubation at 37°C, the cells were centrifuged, and the pellet was lysed with 3 mL of supplemented lysis buffer #4 (1X) for 30 minutes at RT under gentle shaking.

Serial dilutions of the cell lysate were performed using supplemented lysis buffer, and 16 µL of each dilution were transferred into a low volume white microplate before the addition of 4 µL of premixed HTRF total JAK3 detection reagents. Equal amounts of lysates were used for a side-by-side comparison between HTRF and Western Blot.

Using the HTRF total JAK3 assay, 1,560 cells/well were enough to detect a significant signal, while 6,250 cells were needed to obtain a minimal chemiluminescent signal using Western Blot. Therefore, in these conditions, the HTRF total JAK3 assay was 4 times more sensitive than the Western Blot technique.

Comparison between HTRF and WB sensitivity on Total JAK3

JAK3 Signaling Pathway

JAK3 in combination with JAK1 associates exclusively with the IL-2Rγ family receptors that are activated by IL-2, IL-4, IL-7, IL-9, IL-15, & IL-21. Upon receptor activation, JAK3 and JAK1 transphosphorylate each other, and then activate the transcription factors STAT1, STAT3, STAT5, and STAT6. In turn they dimerize and translocate to the nucleus to trigger the transcription of genes regulating lymphocyte maturation, survival, activation, and differentiation.

HTRF cellular phospho-protein assays

Physiologically relevant results fo fast flowing research - Flyers

Best practices for analyzing brain samples with HTRF® phospho assays for neurosciences

Insider Tips for successful sample treatment - Technical Notes

Optimize your HTRF cell signaling assays on tissues

HTRF and WB compatible guidelines - Technical Notes

Best practices for analyzing tumor xenografts with HTRF phospho assays

Protocol for tumor xenograft analysis with HTRF - Technical Notes

Key guidelines to successful cell signaling experiments

Mastering the art of cell signaling assays optimization - Guides

HTRF® phospho-protein platform facilitates the dissection of signaling pathways involved in insulin resistance and metabolic disorders

Multi-tissue cellular modeling and anlysis of insulin signaling - Posters

HTRF® cell signaling platform combined with iCell® Hepatocytes

A solution for phospho-protein analysis in metabolic disorders - Posters

HTRF phospho-assays reveal subtle drug-induced effects

Detailed protocol and direct comparison with WB - Posters

Implement HTRF phospho-protein assays at every step of the drug discovery process, from in vitro to in vivo models

A single technology for 2D cells, 3D cells, and xenograft models - Posters

Simplify complex pathway dissection by combining the power of HTRF® cellular phospho-assays and the flexibility of the CyBi®-FeliX liquid handling system

PI3K/AKT/mTor translational control pathway - Posters

Universal HTRF® phospho-protein platform: from 2D, 3D, primary cells to patient derived tumor cells

Analysis of a large panel of diverse biological samples and cellular models - Posters

From 2D, 3D cell cultures to xenografts: A smart HTRF platform to maximize anticancer drug discovery

One technology across all samples - Application Notes

HTRF phospho assays reveal subtle drug induced effects in tumor-xenografts

Tumor xenograft analysis: HTRF versus Western blot - Application Notes

HTRF cell-based phospho-protein data normalization

Valuable guidelines for efficiently analyzing and interpreting results - Application Notes

HTRF phospho-total lysis buffer: a universal alternative to RIPA lysis buffers

Increased flexibility of phospho-assays - Application Notes

HTRF Alpha-tubulin Housekeeping kit

Properly interpret your compound effect - Application Notes

Simplified pathway dissection with HTRF phospho-assays and CyBi-felix liquid handling

Analyse of PI3K/AKT/mTor translational control pathway - Application Notes

How to run a cell based phospho HTRF assay

What to expect at the bench - Videos

Cell-based kinase assays in HTS ? potential and limitations for primary and secondary screening

In collaboration with Bayer - Scientific Presentations

Unleash the potential of your phosphorylation research with HTRF

A fun video introducing you to phosphorylation assays with HTRF - Videos

How to run a cell based phospho HTRF assay

3' video to set up your Phospho assay - Videos

Product Insert JAK3 total Kit / 64JAK3TPEG-64JAK3TPEH

64JAK3TPEG-64JAK3TPEH - Product Insert

Guidelines for Cell Culture and Lysis in Different Formats Prior to HTRF Detection

Seeding and lysing recommendations for a number of cell culture vessels. - Technical Notes

Assessment of drug efficacy and toxicity by combining innovative technologies

Combination of AlphaLISA®, HTRF®, or AlphaLISA® SureFire® Ultra™ immunoassays with the ATPlite™ 1step cell viability assay - Application Notes

Methodological Aspects of Homogeneous Time-Resolved Fluorescence (HTRF)

Learn how to reduce time and sample consumption - Application Notes

Safety Data Sheet (DEU) JAK3 total Kit / 64JAK3TPEG